ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed
Brian J. McCarthy
Matched on NIH RePORTER profile ID 8335686.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 1
- Collaborators
- 11
2018: 1 paper · 2019: none · 2020: 1 grant · 2021: none · 2022: 2 papers
Papers 3
- Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer. Co-author DOI 10.1002/cncr.34269↗
- ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer. Co-author DOI 10.3390/cancers14122906↗
- Circulating Tumor and Invasive Cell Gene Expression Profile Predicts Treatment Response and Survival in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers10120467↗
Grants 1
Closest collaborators
The 11 strongest of 11 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Kenneth H. Yu · 3 shared papers, 1 shared grant, 2018–2022
- Grant Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer R01CA202762↗
- Paper ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer. DOI 10.3390/cancers14122906↗
- Paper Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer. DOI 10.1002/cncr.34269↗
- Mark Ricigliano · 1 shared paper, 1 shared grant, 2018–2020
- William H. Isacoff · 1 shared paper, 2022
- Eileen Mary O'Reilly · 2 shared papers, 2018–2022
- Marinela Capanu · 2 shared papers, 2018–2022
- Anna M. Varghese · 1 shared paper, 2022
- Ghassan K. Abou-Alfa · 1 shared paper, 2022
- Wungki Park · 1 shared paper, 2022
- Andrew S. Epstein · 1 shared paper, 2022
- David Paul Kelsen · 1 shared paper, 2022
- Maeve Aine Lowery · 1 shared paper, 2018
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.